-
Mashup Score: 3
Nature – The FDA’s accelerated-approval process was designed to help people access life-saving drugs. But gaps in communication could mean that people are undergoing treatments known to be…
Source: www.nature.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0
This cross-sectional study evaluates patient exposure to oncology drugs withdrawn from the US Food and Drug Administration (FDA) Accelerated Approval program.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Prior Auth Is a Self-Inflicted Wound; Is There a Way Out? - 9 month(s) ago
Ravi B. Parikh, MD, MPP, explores the growing burden of prior authorization, why it’s happening, and how we can start to fix it from the inside.
Source: www.medscape.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Daily, I see posts from doctors railing on #insurance co. abt prior auth. But when payers are only agent incentivized to lower costs, prior auth results. Let's not shout at the wind; instead put teeth behind cost-conscious care efforts. My latest @Medscape https://t.co/fq4IyvRAUH https://t.co/iGUOZzNrXY
-
-
Mashup Score: 1Medicaid Expansion Associated With Increase In Palliative Care For People With Advanced-Stage Cancers - 9 month(s) ago
Clinical guidelines have endorsed early palliative care for patients with advanced malignancies, but receipt remains low in the US. This study examined the association between Medicaid expansion under the Affordable Care Act and receipt of palliative care among patients newly diagnosed with advanced-stage cancers. Using the National Cancer Database, we found that the percentage of eligible patients who received palliative care as part of first-course treatment increased from 17.0 percent preexpansion to 18.9 percent postexpansion in Medicaid expansion states and from 15.7 percent to 16.7 percent, respectively, in nonexpansion states, resulting in a net increase of 1.3 percentage points in expansion states in adjusted analyses. Increases in receipt of palliative care associated with Medicaid expansion were largest for patients with advanced pancreatic, colorectal, lung, and oral cavity and pharynx cancers and non-Hodgkin lymphoma. Our findings suggest that increasing Medicaid coverage f
Source: www.healthaffairs.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Innovation in Prostate Cancer Care: Frailty, Bone Health, and Cardiovascular Screening - Ravi B. Parikh - 11 month(s) ago
In this discussion, Alicia Morgans interviews Ravi Parikh about his session on interventions to prevent or mitigate frailty in prostate cancer patients. Parikh emphasizes the necessity of screening for frailty and tailoring treatment strategies for older patients who may experience different side effects. He elaborates on strategies such as prehabilitation before prostate cancer surgery and…
Source: UroTodayCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1How do we regulate AI in healthcare? | Haclab - 11 month(s) ago
This has been on the minds of the Food and Drug Administration (FDA), as it has released several pieces of guidance for using AI in areas such as drug development and software as a medical device over the past 5 years. The intention of these documents is to try to stay ahead of the rapid expansion of AI into clinical care. Over 500 AI and machine learning devices have been cleared by the FDA –…
Source: haclab.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1HACLab at the 2023 AcademyHealth Annual Research Meeting! | Haclab - 11 month(s) ago
Sign up for HACLAB updates Contact us Human Algorithm Collaboration Lab Emailhaclab@pennmedicine.upenn.edu …
Source: haclab.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Qualtrics Survey | Qualtrics Experience Management - 12 month(s) ago
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
Source: upenn.co1.qualtrics.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Effect of Machine Learning–Triggered Nudges on Serious Illness Conversations With Patients With Cancer - 1 year(s) ago
This randomized clinical trial assesses the impact of behavioral nudges to clinicians on the rate of serious illness conversations and end-of-life outcomes among patients at high risk of death.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5Healio Disruptive Innovators Awards 2023 - 1 year(s) ago
Vote for your 2023 Healio Disruptive Innovators!
Source: www.surveymonkey.comCategories: Hem/Oncs, Latest HeadlinesTweet
Fantastic, nuanced article by @smjyoti @Nature on @US_FDA Accelerated Approval Program, ft. our @JAMAOnc work on exposure to withdrawn drugs. Stay tuned for work w/ @Ron_cology @RhubbBstat @SteveJoffe @Arnold_Ventures to inform next gen of program https://t.co/bIWIw67DAR